title: Protective effect of post-ischaemic viral delivery of heat shock proteins in vivo.
abstract: Heat shock proteins (HSPs) function as molecular chaperones involved in protein folding, transport and degradation and, in addition, they can promote cell survival both in vitro and in vivo after a range of stresses. Although some in vivo studies have suggested that HSP27 and HSP70 can be neuroprotective, current evidence is limited, particularly when HSPs have been delivered after an insult. The effect of overexpressing HSPs after transient occlusion of the middle cerebral artery in rats was investigated by delivering an attenuated herpes simplex viral vector (HSV-1) engineered to express HSP27 or HSP70 30 mins after tissue reperfusion. Magnetic resonance imaging scans were used to determine lesion size and cerebral blood flow at six different time points up to 1 month after stroke. Animals underwent two sensorimotor tests at the same time points to assess the relationship between lesion size and function. Results indicate that post-ischaemic viral delivery of HSP27, but not of HSP70, caused a statistically significant reduction in lesion size and induced a significant behavioural improvement compared with controls. This is the first evidence of effective post-ischaemic gene therapy with a viral vector expressing HSP27 in an experimental model of stroke.
authors.affiliation: RCS Unit of Biophysics, UCL Institute of Child Health, London, UK. rabadin@yahoo.com
authors.forename: Romina A
authors.initials: RA
authors.lastname: Badin
authors.forename: Michael
authors.initials: M
authors.lastname: Modo
authors.forename: Mike
authors.initials: M
authors.lastname: Cheetham
authors.forename: David L
authors.initials: DL
authors.lastname: Thomas
authors.forename: David G
authors.initials: DG
authors.lastname: Gadian
authors.forename: David S
authors.initials: DS
authors.lastname: Latchman
authors.forename: Mark F
authors.initials: MF
authors.lastname: Lythgoe
mesh_terms: D000818:Animals; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics; D055551:HSP27 Heat-Shock Proteins / Q000235:genetics / Q000378:metabolism*; D018840:HSP70 Heat-Shock Proteins / Q000235:genetics / Q000378:metabolism*; D018259:Herpesvirus 1, Human / Q000235:genetics*; D007511:Ischemia / Q000235:genetics* / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D055551:HSP27 Heat-Shock Proteins; D018840:HSP70 Heat-Shock Proteins
references.citation: Stroke. 1997 Oct;28(10):2060-5; discussion 2066
references.pmid: 9341719
references.citation: Trends Neurosci. 1999 Dec;22(12):535-40
references.pmid: 10542428
references.citation: Neuron. 2002 Sep 26;36(1):45-56
references.pmid: 12367505
references.citation: Stroke. 1988 Sep;19(9):1083-92
references.pmid: 3413804
references.citation: Brain Res. 1994 Jan 21;634(2):235-44
references.pmid: 8131073
references.citation: Mol Cell Biol. 2000 Oct;20(19):7146-59
references.pmid: 10982831
references.citation: J Biol Chem. 1999 Jul 2;274(27):18947-56
references.pmid: 10383393
references.citation: J Cereb Blood Flow Metab. 2001 Nov;21(11):1303-9
references.pmid: 11702045
references.citation: J Biol Chem. 1996 Jul 12;271(28):16510-4
references.pmid: 8663291
references.citation: Annu Rev Biochem. 1998;67:425-79
references.pmid: 9759494
references.citation: Stroke. 1995 Dec;26(12):2313-9; discussion 2319-20
references.pmid: 7491657
references.citation: J Cereb Blood Flow Metab. 2006 Mar;26(3):371-81
references.pmid: 16079790
references.citation: J Cereb Blood Flow Metab. 2006 Jan;26(1):38-47
references.pmid: 15988477
references.citation: Cell Death Differ. 2002 May;9(5):483-5
references.pmid: 11973606
references.citation: Arch Intern Med. 2000 Nov 27;160(21):3196-206
references.pmid: 11088079
references.citation: J Cereb Blood Flow Metab. 1996 Nov;16(6):1236-49
references.pmid: 8898697
references.citation: Pharmacol Ther. 1998 Nov;80(2):183-201
references.pmid: 9839771
references.citation: J Cell Sci. 1997 Feb;110 ( Pt 3):357-68
references.pmid: 9057088
references.citation: J Neurochem. 1999 Jul;73(1):229-36
references.pmid: 10386975
references.citation: J Neurosci Methods. 2000 Dec 15;104(1):99-109
references.pmid: 11163416
references.citation: Am J Physiol Renal Physiol. 2005 Jun;288(6):F1236-42
references.pmid: 15701813
references.citation: Stroke. 1994 Oct;25(10):1973-6
references.pmid: 8091440
references.citation: Pharmacol Biochem Behav. 1982 Mar;16(3):455-62
references.pmid: 7079281
references.citation: Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12766-71
references.pmid: 11606760
references.citation: J Neurosci. 2003 Jan 15;23(2):510-7
references.pmid: 12533611
references.citation: Exp Neurol. 1988 Dec;102(3):318-24
references.pmid: 3197789
references.citation: Curr Neurovasc Res. 2004 Jan;1(1):21-7
references.pmid: 16181063
references.citation: Trends Pharmacol Sci. 1998 Feb;19(2):59-66
references.pmid: 9550943
references.citation: Magn Reson Imaging. 1995;13(1):73-80
references.pmid: 7898282
references.citation: Trends Neurosci. 1999 Mar;22(3):97-9
references.pmid: 10199631
references.citation: Nat Cell Biol. 2000 Aug;2(8):476-83
references.pmid: 10934467
references.citation: Magn Reson Med. 1995 Aug;34(2):139-43
references.pmid: 7476070
references.citation: Brain Res. 1992 Mar 20;575(2):238-46
references.pmid: 1571783
references.citation: Cell Stress Chaperones. 1998 Dec;3(4):228-36
references.pmid: 9880235
references.citation: Mol Cell Biol. 2002 Feb;22(3):816-34
references.pmid: 11784858
references.citation: J Biol Chem. 1999 Nov 19;274(47):33235-43
references.pmid: 10559197
references.citation: J Biol Chem. 2003 May 30;278(22):19956-65
references.pmid: 12639970
references.citation: J Cereb Blood Flow Metab. 1996 Jul;16(4):705-13
references.pmid: 8964811
references.citation: Glia. 2002 Apr 1;38(1):1-14
references.pmid: 11921199
references.citation: Phys Med Biol. 2000 Aug;45(8):R97-138
references.pmid: 10958179